Diphtheria-Tetanus-acellular Pertussis Vaccines
"Diphtheria-Tetanus-acellular Pertussis Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Combined vaccines consisting of DIPHTHERIA TOXOID; TETANUS TOXOID; and an acellular form of PERTUSSIS VACCINE. At least five different purified antigens of B. pertussis have been used in various combinations in these vaccines.
| Descriptor ID |
D022681
|
| MeSH Number(s) |
D20.215.894.135.535.295 D20.215.894.691.263.290 D20.215.894.691.824.290 D20.215.894.815.149 D20.215.894.860.900.267
|
| Concept/Terms |
Diphtheria-Tetanus-acellular Pertussis Vaccines- Diphtheria-Tetanus-acellular Pertussis Vaccines
- Diphtheria Tetanus acellular Pertussis Vaccines
- Pertussis Vaccines, Diphtheria-Tetanus-acellular
- Vaccines, Diphtheria-Tetanus-acellular Pertussis
- DTaP Vaccines
- Vaccines, DTaP
- DTaP Vaccine
- Vaccine, DTaP
|
Below are MeSH descriptors whose meaning is more general than "Diphtheria-Tetanus-acellular Pertussis Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Diphtheria-Tetanus-acellular Pertussis Vaccines".
This graph shows the total number of publications written about "Diphtheria-Tetanus-acellular Pertussis Vaccines" by people in this website by year, and whether "Diphtheria-Tetanus-acellular Pertussis Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 6 | 3 | 9 |
| 2018 | 12 | 2 | 14 |
| 2019 | 9 | 2 | 11 |
| 2020 | 2 | 2 | 4 |
| 2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Diphtheria-Tetanus-acellular Pertussis Vaccines" by people in Profiles.
-
BNT162b2 mRNA Vaccine Interference with Co-Administration of Tdap Vaccine. Am J Case Rep. 2021 Jul 25; 22:e933003.
-
Vaccines and Disease Relapses in Children with Nephrotic Syndrome. Clin J Am Soc Nephrol. 2021 06; 16(6):937-938.
-
Methodologic approaches in studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women: A scoping review. Vaccine. 2021 06 29; 39(29):3814-3824.
-
Caregiver and service provider vaccine confidence following the Changchun Changsheng vaccine incident in China: A cross-sectional mixed methods study. Vaccine. 2020 10 14; 38(44):6882-6888.
-
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020 Aug 21; 69(33):1109-1116.
-
Effectiveness of Acellular Pertussis Vaccine in Older Adults: Nested Matched Case-control Study. Clin Infect Dis. 2020 07 11; 71(2):340-350.
-
Quantity and Quality of Antibodies After Acellular Versus Whole-cell Pertussis Vaccines in Infants Born to Mothers Who Received Tetanus, Diphtheria, and Acellular Pertussis Vaccine During Pregnancy: A Randomized Trial. Clin Infect Dis. 2020 06 24; 71(1):72-80.
-
Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999-2015. J Pediatric Infect Dis Soc. 2020 Apr 30; 9(2):118-127.
-
Vital Signs: Burden and Prevention of Influenza and Pertussis Among Pregnant Women and Infants - United States. MMWR Morb Mortal Wkly Rep. 2019 Oct 11; 68(40):885-892.
-
The health and economic burden of pertussis in Canada: A microsimulation study. Vaccine. 2019 11 20; 37(49):7240-7247.